178 related articles for article (PubMed ID: 26283745)
1. High Antimalarial Efficacy of Dihydroartemisinin-Piperaquine on the China-Myanmar Border: The Calm Before the Storm.
Fairhurst RM
Am J Trop Med Hyg; 2015 Sep; 93(3):436-437. PubMed ID: 26283745
[No Abstract] [Full Text] [Related]
2. Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
Phuc BQ; Rasmussen C; Duong TT; Dong LT; Loi MA; Ménard D; Tarning J; Bustos D; Ringwald P; Galappaththy GL; Thieu NQ
Emerg Infect Dis; 2017 Apr; 23(4):715-717. PubMed ID: 28322709
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
[TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria at the China-Myanmar Border.
Wang Y; Yang Z; Yuan L; Zhou G; Parker D; Lee MC; Yan G; Fan Q; Xiao Y; Cao Y; Cui L
Am J Trop Med Hyg; 2015 Sep; 93(3):577-83. PubMed ID: 26283743
[TBL] [Abstract][Full Text] [Related]
5. Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Retain High Efficacy for Treatment of Uncomplicated
Han KT; Lin K; Myint MK; Thi A; Aye KH; Han ZY; Moe M; Bustos MD; Rahman MM; Ringwald P; Simmons R; Markwalter CF; Plowe CV; Nyunt MM
Am J Trop Med Hyg; 2020 Mar; 102(3):598-604. PubMed ID: 31833468
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
[TBL] [Abstract][Full Text] [Related]
7. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
McLean ARD; Indrasuta C; Khant ZS; Phyo AK; Maung SM; Heaton J; Aung H; Aung Y; Soe K; Swe MMM; von Seidlein L; Tun NN; Tun KM; Day NPJ; Ashley EA; Hlaing T; Kyaw TT; Dondorp AM; Imwong M; White NJ; Smithuis FM
Lancet Infect Dis; 2021 Nov; 21(11):1579-1589. PubMed ID: 34147154
[TBL] [Abstract][Full Text] [Related]
8. In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013.
Liu H; Yang HL; Tang LH; Li XL; Huang F; Wang JZ; Li CF; Wang HY; Nie RH; Guo XR; Lin YX; Li M; Wang J; Xu JW
Malar J; 2015 Feb; 14():47. PubMed ID: 25652213
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand.
Boonyalai N; Thamnurak C; Sai-Ngam P; Ta-Aksorn W; Arsanok M; Uthaimongkol N; Sundrakes S; Chattrakarn S; Chaisatit C; Praditpol C; Fagnark W; Kirativanich K; Chaorattanakawee S; Vanachayangkul P; Lertsethtakarn P; Gosi P; Utainnam D; Rodkvamtook W; Kuntawunginn W; Vesely BA; Spring MD; Fukuda MM; Lanteri C; Walsh D; Saunders DL; Smith PL; Wojnarski M; Sirisopana N; Waters NC; Jongsakul K; Gaywee J
Sci Rep; 2021 Jun; 11(1):13419. PubMed ID: 34183715
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
Lwin KM; Phyo AP; Tarning J; Hanpithakpong W; Ashley EA; Lee SJ; Cheah P; Singhasivanon P; White NJ; Lindegårdh N; Nosten F
Antimicrob Agents Chemother; 2012 Mar; 56(3):1571-7. PubMed ID: 22252804
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ
J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
14. Skirmishing over the scope of the threat.
Roberts L
Science; 2016 Apr; 352(6284):403. PubMed ID: 27102460
[No Abstract] [Full Text] [Related]
15. Baseline
Robert MG; Foguim Tsombeng F; Gendrot M; Diawara S; Madamet M; Kounta MB; Wade KA; Fall M; Gueye MW; Benoit N; Nakoulima A; Bercion R; Amalvict R; Fall B; Wade B; Diatta B; Pradines B
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782997
[TBL] [Abstract][Full Text] [Related]
16. Implications of the MDA Trial in Southern Province, Zambia, for Malaria Control and Elimination.
Steketee RW; Miller JM; Chizema Kawesha E
Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):98-101. PubMed ID: 32618248
[No Abstract] [Full Text] [Related]
17. [Therapeutic efficacy and safety of compound dihydroartemisinin/piperaquine for uncomplicated Plasmodium falciparum infection in Laiza City of Myanmar bordering on China].
Sun XD; Zhang ZX; Wang J; Deng Y; Yang YC; Lasi JH; Sun XY; Wang H
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Oct; 29(5):372-5. PubMed ID: 24830201
[TBL] [Abstract][Full Text] [Related]
18. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
[TBL] [Abstract][Full Text] [Related]
19. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
[TBL] [Abstract][Full Text] [Related]
20. Changing Antimalarial Drug Sensitivities in Uganda.
Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
